News | Otsuka Medical Devices Co., Ltd.

OCT

2023

News Releases

Recor Medical Announces Positive Results from Six-Month Pooled Analysis of Data from the RADIANCE Global Clinical Trial Program at TCT 2023 (Link to Recor website)

OCT

2023

News Releases

Recor Medical to Present Latest Clinical Data on Paradise™ Ultrasound Renal Denervation at TCT Annual Meeting (Link to Recor website)

AUG

2023

News Releases

Otsuka Medical Devices and Recor Medical Announce Positive Vote from U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on the Paradise™ Ultrasound Renal Denervation System for the Treatment of Hypertension

JUL

2023

News Releases

ReCor Responds to European Society of Hypertension's (ESH) Updated Guidelines for Management of Arterial Hypertension (Link to ReCor website)

MAR

2023

News Releases

Otsuka Medical Devices appoints Board Members and Audit & Supervisory Board Members

FEB

2023

News Releases

Announces Two Concurrent JAMA Network Publications of Study Results on the Paradise Ultrasound Renal Denervation System for the Treatment of Hypertension (Link to ReCor website)

JAN

2023

News Releases

ReCor Medical Names Lara Barghout President and Chief Executive Officer (Link to ReCor website)

DEC

2022

News Releases

Otsuka Medical Devices has entered into an exclusive agreement with CSI to distribute Diamondback 360^®Coronary Orbital Atherectomy System in Japan

NOV

2022

News Releases

Submission of Application for Pre-Market Approval of the Paradise™ Ultrasound Renal Denervation (uRDN) System to the U.S. Food and Drug Administration

NOV

2022

News Releases

Otsuka Medical Devices certified to ISO 13485　

News release content on our website informs stakeholders about our corporate activities, including updates on medical devices and products under development. It is intended for the media, shareholders, investors, and other interested parties, and not for promotional, advertising, or medical advice purposes.